1. bookVolume 21 (2020): Issue 2 (June 2020)
Journal Details
License
Format
Journal
First Published
23 Apr 2014
Publication timeframe
4 times per year
Languages
English
Copyright
© 2020 Sciendo
Journal Details
License
Format
Journal
First Published
23 Apr 2014
Publication timeframe
4 times per year
Languages
English
Copyright
© 2020 Sciendo

This review summarizes the data regarding the gas transport characteristics of hemocorrection and perfusates on the basis of low concentrated drugs nano-sized perfluorocarbonic 20% Perftoran (a blood substitute, it is allowed for clinical use in Russia), 20% Ftoremulsion III (an improved blood substitute, registered in Russia), 10-20% Perfusol (a perfusion solution for perfusion of the isolated heart), 20% Ftorem (a cardioplegic emulsion for surgeries on the stopped heart) used in the biomedical field. The compensation of blood loss using traditional plasma substitutes without the gas transport function or with low gas transport characteristics leads to a decrease in the oxygen capacity of the resulting mixture and subsequently to deterioration in the oxygen transport characteristics of blood. The synthetic gas-transport blood substitutes can be used in the treatment of various forms of ischemia, such as carbon monoxide poisoning. Furthermore, recent results regarding the mechanism of COVID19 infection indicate a possible use of the synthetic gas-transport blood substitutes in the treatment and therapy of COVID19 infected patients.

Keywords

1. Afonin NI, Doronina NN. Fluorocarbons as possible blood substitutes for oxygen carriers. Problems of Hematology. 1981; 24(1): 41-45.Search in Google Scholar

2. Beloyartsev FF. Perfluorinated carbon in biology and medicine. Perfluorinated carbon in biology and medicine: SB. Pushchino. 1980; 5-21.Search in Google Scholar

3. Beloyartsev FF, Kaidash AN, Islamov BI. Cardioplegia with fluorocarbon emulsion as a method of protecting the myocardium during heart operations. Medico-biological aspects of perfluorocarbon emulsions application. Pushchino SB. 1983. pp. 116-127.Search in Google Scholar

4. Vorobyev SI, Vasiliev AE, Islamov BI. Evaluation of the possibility of using perfluorocarbon emulsion for normothermic perfusion of an isolated heart. Pathophysiology and experimental therapy. 1991; N6: 34-36.Search in Google Scholar

5. Vorobyev SI, Ladilov YuV, Islamov BI. Anti-ischemic effect of perfluorocarbon emulsion on the myocardium of dogs. Bulletin of experimental biology and medicine. 1991. No. 2. C.Search in Google Scholar

6. Vorobyev SI, Islamov BI, Ladilov YuV. Тhe possibility of using perfluorocarbon emulsions for long-term preservation of the donor heart. g. Thoracic and cardiovascular surgery. 1990. No. 4. pp. 38-41.Search in Google Scholar

7. Vorobyev SI, Ivanitsky GR, Makarov KN. Perfluorocarbon emulsions Russian Academy of Sciences. Preprint. Pushchino, 1993, p. 28.Search in Google Scholar

8. Vorobyev SI, Ivanitsky GR., Moroz VV. Gas transport preparations based on perfluorocarbon emulsions. Bulletin of intensive care, 1996; 2-3: 15-21.Search in Google Scholar

9. Vorobyev SI. Perfluorocarbon – based Emulsion-Perftoran is a multifunctional drug with a gas transport function. Topical issues of Hematology and Transfusiology. St. Petersburg. 1996. p. 80.Search in Google Scholar

10. Vorobyev SI. Perfluorocarbon blood-substituting emulsion Perftoran: chronology of creation. Vestnik RAEN. 2007; 7(1): 98-108.Search in Google Scholar

11. Vorobyev SI, Moiseenko OM, Belyaev BL. Colloidalchemical and medico-biological characteristics of perfluorocarbon preparation “Fluoroemulsion III”. Zh. Chemico-pharmaceutical journal. 2009; 43(5): 37-43.Search in Google Scholar

12. Vorobyev SI. Perfluorocarbon blood-substituting emulsions of I and II generation. Zh. Chemico-pharmaceutical journal. 2009; 43(4): 30-40.Search in Google Scholar

13. Ivanitsky GR, Vorobyev SI. Blood-substituting Perftoran. Zh. Vestnik RAS. 1997; 67(11): 998-1008.Search in Google Scholar

14. Kuznetsova IN. Influence of perfluorocarbon emulsions on rheological parameters of blood. Biophysics. 2001; 46(4): 761-764.Search in Google Scholar

15. Kuznetsova IN. Functional activity and stability of perfluorocarbon emulsions. Autoref. doctor. Diss. 1999.Search in Google Scholar

16. Knunyants IL, Makarov KN, Snegirev VF. Perfto-N - (4-methylcyclohexyl) - piperidine as the basis of gas-carrying perfusion media. Author of St. No. 1094287. 1984.Search in Google Scholar

17. Makarov KN, Mirzabekyants NS, Snegirev VF, Melnichenko BA, Prokudin IP, Maksimov BN, Yakhlakova OM, Knunyants IL. Synthesis and physical and chemical characteristics of perfluoroalkyl - and 1,4 dialkyl-substituted cyclohexanes. Perfluorinated carbon in biology and medicine. Pushchino SB. 1980. pp. 21-30.Search in Google Scholar

18. 18.Clark L, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at a atmospheric pressure. Science. 1966; 152: 1752-1755.Search in Google Scholar

19. Geyer R. (1978). Perfluorochemical blood replacemen preparations. IV International Symposium on perfluorochemical blood substitutes. Kyoto, Japan. 1978. (pp 3-32).Search in Google Scholar

20. Naito R, Yokoyama K. (1977). Improvement of perfluorodecalin emulsion with special regard to in vivo stadity, offering “Fluosol-DA”. Research on Perfluorochemicals in Medicins and Biology. Stockholm, Sweden. April 1977. (p 42).Search in Google Scholar

21. Riess J, Flaim S, Rlein D. The relative physiocochemical and biological attributes of perflubrom emulation. / / Physiological activity of fluorinated compounds. Pushchino SB. 1995. pp. 73-90.Search in Google Scholar

22. Riess J, Cornelus C, Krafft M. Fluorocarbon emulation stabilization and particle size control using mixed fluorocarbon. Physiological activity of fluorocarbon compounds: Pushchino Collection. 1995; 67-73.Search in Google Scholar

23. Wenzhong L, Hualan L. (2020): COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. ChemRxiv. Preprint. https://doi.org/10.26434/chemrxiv.11938173.v7Search in Google Scholar

Plan your remote conference with Sciendo